New York, USA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Leading...
Novartis AG (NYSE: NVS) confirmed its plans for a 100% spin-off of the Sandoz business on October 4 after shareholders approved it earlier this month. Novartis also said key...
Novartis AG (NYSE: NVS) released topline data from the Phase 3 NETTER-2 trial with Lutathera, a radioligand therapy (RLT) for advanced gastroenteropancreatic neuroendocrine tumors...
New York, USA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market -...
BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, from Novartis AG (NYSE: NVS). Under the...
At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders approved the proposed 100% spin-off of Sandoz. Novartis shareholders and Novartis ADR holders will...
New York, USA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Peanut Allergy Market to Accelerate Substantially by 2032, Examines DelveInsight | Leading Companies - Vedanta, Allergy, COUR...